Liver cancer survival rates reflect income disparities

Published Date: 06 May 2025

The risk of dying from the most common form of primary liver cancer is about 30% higher for patients with low household income compared to those with middle or high household income, according to a study from the University ...

Read Full News

Todays Updates


Apr 10 2026 This Week in Cardiology


Three imaging-guided PCI trials (two with surprising results), LDL targets, an oral PCSK9 inhibitor, and another beta-blocker withdrawal trial are the topics John Mandrola, MD, discusses in this week’s podcast.

How the Gulf Crisis Is Reaching Europe’s Pharmacies


Conflict in the Gulf is exposing how dependent Europe’s pharmacies are on global supply chains for essential medicines, active ingredients, and transport.

Acute Severe Ulcerative Colitis: 10 Risks in Older Adults


Older adults with acute severe ulcerative colitis have higher mortality, underscoring the need for targeted strategies to reduce the risk for adverse events and enable timely treatment decisions.

The Flaws in the New HHS Nutrition Education Initiative


Doctors aren't dietitians. Fantuzzi and Straughan unpack the flaws in the new HHS nutrition competencies and advocate for collaborative care.

Kennedy Broadens Vaccine Advisory Panel's Role to Focus on Risks


U.S. Health Secretary Robert F. Kennedy Jr. on Thursday issued a new charter for a CDC vaccine advisory committee that expands the role of the panel to include a ⁠focus on...

Phage Therapy Gains Momentum in Antibiotic Resistance


Growing antimicrobial resistance is prompting renewed interest in phage therapy, with preliminary data indicating improved outcomes when combined with standard antibiotics.

Should US Policies Qualify as a Global Health Emergency?


Debate is growing over whether national policy decisions can meet the criteria for global health emergencies, as projections suggest major setbacks in infectious disease control.

Todays Updates


Apr 10 2026 This Week in Cardiology


Three imaging-guided PCI trials (two with surprising results), LDL targets, an oral PCSK9 inhibitor, and another beta-blocker withdrawal trial are the topics John Mandrola, MD, discusses in this week’s podcast.

How the Gulf Crisis Is Reaching Europe’s Pharmacies


Conflict in the Gulf is exposing how dependent Europe’s pharmacies are on global supply chains for essential medicines, active ingredients, and transport.

Acute Severe Ulcerative Colitis: 10 Risks in Older Adults


Older adults with acute severe ulcerative colitis have higher mortality, underscoring the need for targeted strategies to reduce the risk for adverse events and enable timely treatment decisions.

The Flaws in the New HHS Nutrition Education Initiative


Doctors aren't dietitians. Fantuzzi and Straughan unpack the flaws in the new HHS nutrition competencies and advocate for collaborative care.

Kennedy Broadens Vaccine Advisory Panel's Role to Focus on Risks


U.S. Health Secretary Robert F. Kennedy Jr. on Thursday issued a new charter for a CDC vaccine advisory committee that expands the role of the panel to include a ⁠focus on...

Phage Therapy Gains Momentum in Antibiotic Resistance


Growing antimicrobial resistance is prompting renewed interest in phage therapy, with preliminary data indicating improved outcomes when combined with standard antibiotics.

Should US Policies Qualify as a Global Health Emergency?


Debate is growing over whether national policy decisions can meet the criteria for global health emergencies, as projections suggest major setbacks in infectious disease control.

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Kate Middleton and Remission: Oncologists Weigh In

2.

Research indicates that extended PSMA therapy is safe and effective for patients with prostate cancer.

3.

Anti-PD-L1 Plus Targeted Agent No Better Than Chemo for Resistant NSCLC

4.

Year in Review: Multiple Myeloma

5.

'Ticking Time Bomb'; Jimmy Carter's Lasting Impact on Cancer; Breast Cancer-CVD Link


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot